# Vaxcyte, Inc.: Form 8-K, filed Sep 30, 2025

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2025-09-30
- Accepted by EDGAR: Sep 30, 2025, 09:06 ET
- Period: 2025-09-24
- Accession: 0001649094-25-000102
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000102/pcvx-20250924.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000102/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000164909425000102/pcvx-20250924.htm

Filed Sep 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001649094-25-000102. Last ingested by Listed: Nov 4, 2026, 18:37 ET. No prices; not investment advice.